Assembly and publication of the severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) genome in January 2020 enabled the immediate development of tests to detect the …
The December 2019 outbreak of a novel respiratory virus, SARS-CoV-2, has become an ongoing global pandemic due in part to the challenge of identifying symptomatic …
O Vandenberg, D Martiny, O Rochas… - Nature Reviews …, 2021 - nature.com
During the early phase of the coronavirus disease 2019 (COVID-19) pandemic, design, development, validation, verification and implementation of diagnostic tests were actively …
Background Accurate rapid diagnostic tests for SARS‐CoV‐2 infection would be a useful tool to help manage the COVID‐19 pandemic. Testing strategies that use rapid antigen tests …
Rethinking Covid-19 Test Sensitivity As Covid-19 cases accelerate or plateau around the world, we urgently need a point-of-care test that is inexpensive enough to use frequently …
The management of the COVID-19 pandemic has relied on cautious contact tracing, quarantine, and sterilization protocols while we await a vaccine to be made widely available …
A Pekosz, V Parvu, M Li, JC Andrews… - Clinical Infectious …, 2021 - academic.oup.com
Background Individuals can test positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by molecular assays following the resolution of their clinical disease …
Put to the test: use of rapid testing technologies for covid-19 | The BMJ Skip to main content Intended for healthcare professionals Access provided by Google Indexer Subscribe My …
T Peto, D Affron, B Afrough, A Agasu, M Ainsworth… - …, 2021 - thelancet.com
Background Lateral flow device (LFD) viral antigen immunoassays have been developed around the world as diagnostic tests for SARS-CoV-2 infection. They have been proposed to …